AI-guided MRI vs routine MRI for prostate biopsy
Part of Cancer, Kidney & urinary clinical trials.
This study tests whether an artificial intelligence tool for MRI can improve the results of targeted prostate biopsy, compared to the usual method. It could help diagnose prostate cancer more accurately with fewer needles.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 45 to 85 years old.
- You have a recent MRI showing suspicious spots (PI-RADS score 3 or higher).
- You meet the standard reasons for a prostate biopsy (like high PSA, abnormal exam, or past suspicious biopsy results).
- You haven't received prostate cancer treatments such as radiation, hormone therapy, or surgery.
- You can have a biopsy within one month of your MRI.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if an artificial intelligence system can improve MRI scans used to detect prostate cancer. You may join if your doctor has recommended a prostate biopsy and you have an MRI scan that can be reviewed by both radiologists and AI.
This trial tests whether an artificial intelligence (AI) program can help doctors decide when a prostate biopsy is needed. It is for men who have had a prostate MRI that shows either a low-risk (PIRADS 1-2) or uncertain (PIRADS 3) spot, along with a higher-than-normal PSA level. You may qualify if you have certain risk factors like a high PSA density, suspicious digital rectal exam, or family history of prostate cancer.
This trial studies how AI might improve the process of prostate biopsies for people who have had an MRI. It may help if you are scheduled for a biopsy and have not been treated for prostate cancer before.
This study tests an artificial intelligence (AI) tool that may improve how doctors detect prostate cancer using imaging and biopsy information. It could help better identify cancer that is suspected based on PSA blood tests and rectal exam findings.
This trial tests whether an AI program can better spot aggressive prostate cancer on MRI scans, which may help guide treatment decisions. Participation involves having an MRI and possibly a biopsy, and your scan will be analyzed by the software.
This trial compares two ways to guide a prostate biopsy using MRI images, to see which better detects clinically significant prostate cancer in men with suspicious MRI findings.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.